β¨ Medicines Distribution Consents
NEW ZEALAND GAZETTE
24 JUNE
1717
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Ascorbic acid 278 mg, sodium ascorbate 272 mg | Tablet | Nutrilite Products Inc., Buena Park, California, United States of America | Nutriway C-500 |
Dated this 15th day of June 1993.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
gs95267
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Aluminium sulphate 20% w/v | Gel | Hamilton Laboratories Pty Ltd., Adelaide, South Australia | Stingose |
| Ranitidine hydrochloride 150 mg | Tablets | Genpharm Inc., Etobicoke, Ontario, Canada | Zantidin |
| Haemophilus influenzae type b conjugate vaccine containing 10 ug Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid protein in 0.5 ml | Solution for IM injection | Pasteur Merieux Serums et Vaccins, Marcy L'Etoile, France | Act-HIB |
| Dobutamine hydrochloride 250 mg/20 ml | Powder for injection | David Bull Laboratories Pty Ltd., Mulgrave North, Victoria, Australia | Dobutamine Hydrochloride Injection |
| Frusemide 10 mg/ml | Solution for injection | Astra Pharmaceuticals Pty Ltd., North Ryde, New South Wales, Australia | Frusemide injection |
| Iotrolan 0.406 g/ml | Solution for injection | Schering Aktiengesellschaft, Berlin, Germany | Isovist 190 |
| Iotrolan 0.513 g/ml | Solution for injection | Schering Aktiengesellschaft, Berlin, Germany | Isovist 240 |
| Iotrolan 0.641 g/ml | Solution for injection | Schering Aktiengesellschaft, Berlin, Germany | Isovist 300 |
Dated this 22nd day of June 1993.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
gs95268
Consent to the Distribution of Changed Medicines
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Zidovudine 50 mg/5 ml | Oral solution | Wellcome Foundation Ltd., Dartford, Kent, England | Retrovir |
| Captopril 12.5 mg, 25 mg, 50 mg | Tablets | E R Squibb & Sons Ltd., Wirral, Merseyside, England | Capoten |
| Captopril 5 mg/ml | Oral solution | E R Squibb & Sons Ltd., Wirral, Merseyside, England | Capoten |
| Buserelin 1.0 mg/ml | Nasal spray | Hoechst AG, Frankfurt am Main, Germany | Suprefact |
| Ranitidine hydrochloride 150 mg/5 ml | Syrup | Glaxo Operations UK Ltd., Speke, Liverpool, England; Glaxo Operations UK Ltd., Ware, Hertfordshire, England; or Glaxo Operations UK Ltd., Barnard Castle, County Durham, England | Zantac |
| Ranitidine hydrochloride 150 mg, 300 mg | Capsules | Banner Gelatin Products (Canada) Ltd., Olds, Alberta, Canada, or Banner Gelatin Products Corporation, Chatsworth, California, United States of America | Zantac-C |
| Ranitidine hydrochloride 150 mg, 300 mg | Tablets | Glaxo Operations UK Ltd., Ware, Hertfordshire, England; Glaxo Operations UK Ltd., Barnard Castle, County Durham, England; Glaxo Manufacturing Services (NZ) Ltd., Palmerston North, or Glaxo Australia Pty Ltd., Boronia, Victoria, Australia | Zantac |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1993, No 92
NZLII —
NZ Gazette 1993, No 92
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare15 June 1993
Medicines Act 1981, New Related Product, Distribution
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare22 June 1993
Medicines Act 1981, New Medicines, Distribution
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare22 June 1993
Medicines Act 1981, Changed Medicines, Distribution
- C. Lovelace, Director-General of Health